Back to News
Market Impact: 0.2
AstraZeneca Projects $80 Bln In Total Revenue By 2030, Sustained Growth Beyond
Source: Nasdaq
Corporate Guidance & OutlookHealthcare & BiotechCompany Fundamentals
AstraZeneca said it aims to reach $80 billion in total revenue by 2030 and sustain growth beyond that year. The announcement gives a long-term target but provides no further details on the growth drivers or expected annual trajectory.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.30
Ticker Sentiment
AZN0.55
More News
- SK Hynix Posts Record Profit Amid AI Rush
- SK Hynix third-quarter profit sharply beats estimates on AI memory boost
- Anthropic's IPO could be 'speculative fiction' or a 'generational moment' — investors are split
- Tech's relief rally extends as attention turns to tough decisions for the Fed
- Anthropic Gives Traders a Pure-Play Bet on Frontier AI
- Analysis-Hold or sell? High Treasury yields spur US banks to rethink bond portfolios